[English] 日本語
 Yorodumi
Yorodumi- PDB-4qp9: Crystal Structure of ERK2 in complex with 7-(1-propyl-1H-pyrazol-... -
+ Open data
Open data
- Basic information
Basic information
| Entry | Database: PDB / ID: 4qp9 | ||||||
|---|---|---|---|---|---|---|---|
| Title | Crystal Structure of ERK2 in complex with 7-(1-propyl-1H-pyrazol-4-yl)-2-(pyridin-4-yl)-5H-pyrrolo[2,3-b]pyrazine | ||||||
|  Components | Mitogen-activated protein kinase 1 | ||||||
|  Keywords | transferase/transferase inhibitor / Kinase / transferase-transferase inhibitor complex | ||||||
| Function / homology |  Function and homology information phospho-PLA2 pathway / interleukin-34-mediated signaling pathway / Signaling by MAPK mutants / RAF-independent MAPK1/3 activation / Suppression of apoptosis / Gastrin-CREB signalling pathway via PKC and MAPK / Signaling by Activin / cardiac neural crest cell development involved in heart development / caveolin-mediated endocytosis / cytosine metabolic process ...phospho-PLA2 pathway / interleukin-34-mediated signaling pathway / Signaling by MAPK mutants / RAF-independent MAPK1/3 activation / Suppression of apoptosis / Gastrin-CREB signalling pathway via PKC and MAPK / Signaling by Activin / cardiac neural crest cell development involved in heart development / caveolin-mediated endocytosis / cytosine metabolic process / response to epidermal growth factor / Signaling by NODAL / ERKs are inactivated / Signaling by MAP2K mutants / RSK activation / Golgi Cisternae Pericentriolar Stack Reorganization / Regulation of the apoptosome activity / positive regulation of macrophage proliferation / regulation of cellular pH / outer ear morphogenesis / Signaling by LTK in cancer / regulation of Golgi inheritance / positive regulation of peptidyl-threonine phosphorylation / ERBB signaling pathway / labyrinthine layer blood vessel development / mammary gland epithelial cell proliferation / trachea formation / Negative feedback regulation of MAPK pathway / regulation of early endosome to late endosome transport / IFNG signaling activates MAPKs / regulation of stress-activated MAPK cascade / Frs2-mediated activation / positive regulation of macrophage chemotaxis / ERBB2-ERBB3 signaling pathway / Activation of the AP-1 family of transcription factors / regulation of cytoskeleton organization / ERK/MAPK targets / RUNX2 regulates osteoblast differentiation / response to exogenous dsRNA / MAPK1 (ERK2) activation / pseudopodium / lung morphogenesis / face development / positive regulation of telomere maintenance / Bergmann glial cell differentiation / Recycling pathway of L1 / thyroid gland development / Advanced glycosylation endproduct receptor signaling / peptidyl-threonine phosphorylation / regulation of ossification / MAP kinase activity / negative regulation of cell differentiation / RHO GTPases Activate NADPH Oxidases / Regulation of HSF1-mediated heat shock response / Estrogen-dependent nuclear events downstream of ESR-membrane signaling / mitogen-activated protein kinase / RHO GTPases Activate WASPs and WAVEs / Signal attenuation / phosphatase binding / Growth hormone receptor signaling / Estrogen-stimulated signaling through PRKCZ / Schwann cell development / stress-activated MAPK cascade / Nuclear events stimulated by ALK signaling in cancer / NPAS4 regulates expression of target genes / ERK1 and ERK2 cascade / phosphotyrosine residue binding / myelination / Transcriptional and post-translational regulation of MITF-M expression and activity / NCAM signaling for neurite out-growth / RNA polymerase II CTD heptapeptide repeat kinase activity / insulin-like growth factor receptor signaling pathway / cellular response to amino acid starvation / ESR-mediated signaling / lipopolysaccharide-mediated signaling pathway / thymus development / Regulation of PTEN gene transcription / Signal transduction by L1 / B cell receptor signaling pathway / response to nicotine / FCGR3A-mediated phagocytosis / FCERI mediated MAPK activation / Negative regulation of FGFR3 signaling / Negative regulation of FGFR2 signaling / Negative regulation of FGFR4 signaling / Downregulation of SMAD2/3:SMAD4 transcriptional activity / Negative regulation of FGFR1 signaling / SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription / positive regulation of cholesterol biosynthetic process / Spry regulation of FGF signaling / Signaling by high-kinase activity BRAF mutants / MAP2K and MAPK activation / Oncogene Induced Senescence / caveola / regulation of protein stability / Regulation of actin dynamics for phagocytic cup formation / epidermal growth factor receptor signaling pathway / long-term synaptic potentiation / chemotaxis / Interferon gamma signaling Similarity search - Function | ||||||
| Biological species |  Homo sapiens (human) | ||||||
| Method |  X-RAY DIFFRACTION /  SYNCHROTRON /  MOLECULAR REPLACEMENT / Resolution: 2.001 Å | ||||||
|  Authors | Yin, J. / Wang, W. | ||||||
|  Citation |  Journal: Bioorg.Med.Chem.Lett. / Year: 2015 Title: Fragment-based discovery of potent ERK2 pyrrolopyrazine inhibitors. Authors: Burdick, D.J. / Wang, S. / Heise, C. / Pan, B. / Drummond, J. / Yin, J. / Goeser, L. / Magnuson, S. / Blaney, J. / Moffat, J. / Wang, W. / Chen, H. | ||||||
| History | 
 | 
- Structure visualization
Structure visualization
| Structure viewer | Molecule:  Molmil  Jmol/JSmol | 
|---|
- Downloads & links
Downloads & links
- Download
Download
| PDBx/mmCIF format |  4qp9.cif.gz | 154.6 KB | Display |  PDBx/mmCIF format | 
|---|---|---|---|---|
| PDB format |  pdb4qp9.ent.gz | 121.6 KB | Display |  PDB format | 
| PDBx/mmJSON format |  4qp9.json.gz | Tree view |  PDBx/mmJSON format | |
| Others |  Other downloads | 
-Validation report
| Summary document |  4qp9_validation.pdf.gz | 716.2 KB | Display |  wwPDB validaton report | 
|---|---|---|---|---|
| Full document |  4qp9_full_validation.pdf.gz | 719.2 KB | Display | |
| Data in XML |  4qp9_validation.xml.gz | 15.4 KB | Display | |
| Data in CIF |  4qp9_validation.cif.gz | 21.2 KB | Display | |
| Arichive directory |  https://data.pdbj.org/pub/pdb/validation_reports/qp/4qp9  ftp://data.pdbj.org/pub/pdb/validation_reports/qp/4qp9 | HTTPS FTP | 
-Related structure data
| Related structure data |  4qp1C  4qp2C  4qp3C  4qp4C  4qp6C  4qp7C  4qp8C  4qpaC C: citing same article ( | 
|---|---|
| Similar structure data | 
- Links
Links
- Assembly
Assembly
| Deposited unit |  
 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 | 
 | ||||||||
| Unit cell | 
 | 
- Components
Components
| #1: Protein | Mass: 42548.855 Da / Num. of mol.: 1 Source method: isolated from a genetically manipulated source Source: (gene. exp.)  Homo sapiens (human) / Gene: MAPK1, ERK2, PRKM1, PRKM2 / Production host:   Escherichia coli (E. coli) References: UniProt: P28482, mitogen-activated protein kinase | 
|---|---|
| #2: Chemical | ChemComp-35X / | 
| #3: Water | ChemComp-HOH / | 
-Experimental details
-Experiment
| Experiment | Method:  X-RAY DIFFRACTION / Number of used crystals: 1 | 
|---|
- Sample preparation
Sample preparation
| Crystal | Density Matthews: 2 Å3/Da / Density % sol: 38.61 % | 
|---|---|
| Crystal grow | Temperature: 277 K / Method: vapor diffusion, hanging drop / pH: 7.5 Details: 10% PEG3350, 0.2 M proline, and 0.1 M HEPES pH7.5, in a 24-well Linbro plates incubated at 4C, VAPOR DIFFUSION, HANGING DROP, temperature 277K | 
-Data collection
| Diffraction | Mean temperature: 93 K | 
|---|---|
| Diffraction source | Source:  SYNCHROTRON / Site:  ALS  / Beamline: 5.0.2 / Wavelength: 1 Å | 
| Detector | Type: ADSC QUANTUM 315 / Detector: CCD / Date: Nov 20, 2008 | 
| Radiation | Protocol: SINGLE WAVELENGTH / Monochromatic (M) / Laue (L): M / Scattering type: x-ray | 
| Radiation wavelength | Wavelength: 1 Å / Relative weight: 1 | 
| Reflection | Resolution: 2→50 Å / Num. all: 22745 / Num. obs: 22495 / % possible obs: 98.9 % / Observed criterion σ(F): 2 / Observed criterion σ(I): 2 | 
- Processing
Processing
| Software | 
 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Refinement | Method to determine structure:  MOLECULAR REPLACEMENT / Resolution: 2.001→43.74 Å / SU ML: 0.24  / σ(F): 1.34  / Phase error: 25.63  / Stereochemistry target values: ML 
 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Solvent computation | Shrinkage radii: 0.9 Å / VDW probe radii: 1.11 Å / Solvent model: FLAT BULK SOLVENT MODEL | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Refinement step | Cycle: LAST / Resolution: 2.001→43.74 Å 
 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Refine LS restraints | 
 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| LS refinement shell | 
 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Refinement TLS params. | Method: refined / Refine-ID: X-RAY DIFFRACTION 
 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Refinement TLS group | 
 | 
 Movie
Movie Controller
Controller













 PDBj
PDBj
































